Activity of voltage-gated K + (Kv) channels in pulmonary artery smooth muscle cells (PASMC) plays an important role in the control of apoptosis and proliferation, in addition to regulating membrane potential and pulmonary vascular tone. Bone morphogenetic proteins (BMP) inhibit proliferation and induce apoptosis in normal human PASMC, whereas dysfunctional BMP signaling and downregulated Kv channels are involved in pulmonary vascular medial hypertrophy associated with pulmonary hypertension. The goal of this study was to evaluate the effect of BMP-2 on Kv channel function and expression in normal human PASMC. BMP-2 (100 nM for 18-24 hrs) significantly (>2-fold) upregulated mRNA expression of KCNA5, KCNA7, KCNA10, KCNC3, KCNC4, KCNF1, KCNG3, KCNS1, and KCNS3, whereas it downregulated (at least 2-fold) KCNAB1, KCNA2, KCNG2 and KCNV2. The most dramatic change was the >10-fold downregulation of KCNG2 and KCNV2, two electrically silent γ subunits that form heterotetramers with functional Kv channel α subunits (e.g., KCNB1-2). Furthermore, the amplitude and current density of whole-cell Kv currents were significantly increased in PASMC treated with BMP-2. It has been demonstrated that K + currents generated by KCNB1 and KCNG1 (or KCNG2) or KCNB1 and KCNV2 heterotetramers are smaller than those generated by KCNB1 homotetramers, indicating that KCNG2 and KCNV2 (two subunits Kv channel activity may be involved in the proapoptotic and/or antiproliferative effects of BMP-2 on PASMC.
Introduction
Activity of voltage-gated K + (Kv) channels in vascular smooth muscle cells regulates the resting membrane potential and excitation-contraction coupling (57) . The current generated by K + efflux through Kv channels, I K(V) , is heavily influenced by numerous vasoactive agonists that control vascular tone (57) . In pulmonary arterial smooth muscle cells (PASMC) from animals and humans, downregulated Kv channel expression and reduced Kv channel function have been linked to pulmonary vasoconstriction triggered by acute hypoxia (33, 70, 79, 104) and to the sustained pulmonary vasoconstriction and severe pulmonary vascular remodeling induced by chronic hypoxia (69, 81, 88) . Persistent hypoxic pulmonary vasoconstriction and hypoxiamediated pulmonary vascular medial hypertrophy increase pulmonary vascular resistance, which contribute to the development of pulmonary hypertension and subsequent right heart failure in patients with chronic obstructive pulmonary disease and congenital cardiopulmonary diseases, as well as in residents living in high altitude areas.
In addition to contribution to hypoxia-mediated pulmonary hypertension, intimal and medial hypertrophy of small and medium-sized pulmonary arteries are hallmarks of the pulmonary vascular remodeling processes that underlie the development and maintenance of high pulmonary arterial pressure in patients with familial and idiopathic pulmonary arterial hypertension (83) . Overgrowth of PASMC in the pulmonary vascular media is particularly important in the development of pulmonary arterial hypertension because a) sustained PASMC contraction leads to vasoconstriction while excessive PASMC growth enhances the contractile force, and b) PASMC hypertrophy and proliferation cause narrowing of the pulmonary vascular lumen, thereby increasing pulmonary vascular resistance and pulmonary arterial pressure. Idiopathic pulmonary arterial hypertension is pathologically or histologically characterized by severe pulmonary vascular remodeling (due to smooth muscle and endothelial cell proliferation), obliteration of small arteries, intimal fibrosis, small vessel thrombi, and sometimes formation of the plexiform lesion (76) . It is generally believed that multiple genetic and environmental factors are involved in the pathogenesis of familial and idiopathic pulmonary arterial hypertension (99) , such as mutations of bone morphogenetic protein (BMP) receptor type II (BMP-RII) (19, 45, 49, 58) , aberrant regulation of matrix metalloproteins (48, 73) , downregulation of K + channels (98, 101, 105) , upregulation of Ca
2+
-permeable channels (95, 97) , intake of anorexigens (1, 87) , increased production of serotonin and upregulated expression of serotonin receptors and transporter (4, 8, 24, 46) , increased angiopoietin-1 production (21, 23, 84) , elevated endothelin-1 expression and activity (31), and imbalanced cyclic AMP (5, 60) and cyclic GMP (20, 53) metabolism.
A number of factors can modulate PASMC proliferation and apoptosis, including transcription factors (14, 40, 66) , growth factors (47, 55, 97) , and mitogenic agonists (35, 63, 89, 107) . Increased elastase activity and deposition of the matrix metalloprotein tenascin-C also have been linked with the enhanced proliferation in pulmonary arterial hypertension (39, 73) . In some cells, transforming growth factor-β (TGF-β) in particular has been shown to modulate the expression of transcription factors, such as c-Myc (29, 93), thereby regulating cell proliferation and/or survival. Bone morphogenetic proteins (BMPs), members of the TGF-β superfamily also regulate PASMC proliferation, apoptosis, and differentiation (36, 51, 52, 55, 56, 92) via autocrine and paracrine mechanisms. Studies have shown that BMP-2, BMP-4, and BMP-7 can increase the rate of apoptosis and decrease the rate of proliferation of vascular smooth muscle cells (56, 92) , including human PASMC (55, 106) . In PASMC from patients diagnosed with (LCMP-00191-2005 . R6) 5 idiopathic pulmonary arterial hypertension, BMP (BMP-2 and BMP-7)-induced apoptosis was significantly impaired (55, 106) . BMP-2-mediated apoptosis was associated with transient phosphorylation of Smad1, a protein signaling element activated upon binding of BMPs to their type I and II (BMP-RI and -RII) receptors (36, 52) , and with marked downregulation of Bcl-2, an antiapoptotic protein (106) . In an earlier study, Bcl-2 was shown to enhance cell survival or inhibit cell apoptosis by, at least in part, decreasing Kv channel activity and downregulating Kv channel α subunit expression in rat PASMC (25) . This supports the mounting evidence that enhanced K + activity is essential to the onset and progression of PASMC apoptosis (74) . The goal of the current study was to test the hypothesis that BMP-2 increases whole-cell I K(V) by divergently regulating mRNA expression of various Kv channel α/β/γ subunits in human PASMC. In addition, we also examined the effect of BMP-2 on the protein expression of c-Myc, a transcription factor that is upregulated in proliferating cells and downregulated by TGF-β, and explored the possibility that BMP-2 regulates Kv channel expression and promotes cell apoptosis by modulating c-Myc expression.
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MATERIALS AND METHODS
Cell culture and preparation. Human PASMC (passage 4-7) from normal subjects (Cambrex, Walkersville, MD) were derived from pulmonary arteries of three individuals. PASMC were cryopreserved at passage 3, replated onto flasks to amplify cell number for 2-3 passages, and then used for the experiments for 2-3 passages (i.e., at passages 5-8). Cells were seeded and cultured in smooth muscle grown medium (SMGM, Cambrex) in a humidified atmosphere of 5% CO 2 -95% air at 37°C. SMGM was composed of smooth muscle basal medium (SMBM)
supplemented with 5% fetal bovine serum (FBS), 0.5 ng/ml human epidermal growth factor (hEGF), 2 ng/ml human fibroblast growth factor (hFGF), and 5 µg/ml insulin. Proliferating (cultured in SMGM) and growth-arrested (cultured in SMBM) cells were treated with BMP-2 for 18 or 24 hrs prior to experimentation. Identification of the cells in culture as smooth muscle cells was verified using the smooth muscle α-actin monoclonal antibody and the nuclear acid stain, 4', 6'-diamidino-2-phenylindole (DAPI, 5 µM). The DAPI-stained cells also crossreacted with the smooth muscle cell α-actin antibody, indicating that the cultures were all smooth muscle cells. Series resistance compensation was performed in all whole-cell recording experiments.
Measurement of macroscopic I K(V)
Step-pulse protocols and data acquisition were performed using pCLAMP software (Axon Instruments). Leak and capacitative currents were subtracted using the P/4 protocol in pCLAMP software. Currents were filtered at 1-2 kHz (-3 dB) and digitized at 2-4 kHz. Whole-cell
were recorded during 300-ms voltage steps ranging between -60 and +80 mV (in 20 mV increments) from a holding potential of -70 mV. All experiments were performed at room temperature (22-24°C). Current-voltage (I-V) relationship curves report both current amplitude (in pA) and current density (normalized to cell capacitance; pA/pF).
Real-time RT-PCR.
Total RNA was extracted from human PASMC using an RNeasy Mini Kit (Qiagen) according to previously published methods (106 Bioinformatics Design of the Real-Time PCR Assays. Applied Biosystems developed a bioinformatics assay design pipeline that consists of two parts: an assay design engine and an assay evaluation tool. The assay design engine selects primers and probes based on thermodynamic parameters (Tm, nucleotide composition, self-complementarity, etc.) to ensure 100% efficiency of the assays. The assay evaluation component of the pipeline scores the potential hybridization of the assay to closely related genes to produce high specificity assays.
To assess cross-hybridization, the concept of forbidden targets (anti-targets) and a target sequence SuperScriptJ reverse transcriptase (Invitrogen, Carlsbad, CA). RT-PCR was performed by a GeneAmp PCR System (Perkin Elmer, Boston, MA) using a Platinum PCR Supermix (Gibco).
The sequences of sense and antisense primers (Table 2) for the regular RT-PCR experiments were specifically designed from the coding regions of K + channel α and β subunit genes.
Glyceraldehyde phosphate dehydrogenase (GAPDH) was used as an internal control to semiquantify the PCR products and to normalize the PCR products of Kv channel subunits.
Amplified PCR products were separated on 1.5% agarose gels and visualized by ethidium -activated and ATP-sensitive K + currents were markedly minimized under these conditions; the remaining outward K + currents were mainly due to K + efflux through Kv channels. The Kv currents, I K(V) , measured in these human PASMC had similar electrophysiological properties and characteristics to those depicted in our previous studies (68, 69) . The currents were voltage dependent; the threshold for activating the Kv channels was between -45 and -55 mV. Upon depolarizing test potentials, the currents were rapidly activated with a time constant (τ act ) less than 8 ms and slowly inactivated ( mV was 20±10%, 51±13%, 97±26%, 86±19%, 83±19, 64±10, 100±8, and 120±10%, respectively ( Fig. 1C ). BMP-2 treatment had no effect on membrane capacitance (Fig. 1D ), although our previous data indicated that BMP-2 induced significant cell volume decrease (apoptotic volume decrease) and apoptosis (106) . Current amplitude and density were both significantly increased (P<0.01) by BMP-2 at a test potential of -40 mV (Fig. 1E) ; suggesting that BMP-2-sensitive I K(V) is active at potentials close to resting membrane potential in cultured human PASMC. In addition to amplitude and the current density of I K(V) , we also examined whether BMP-2 affected the channel gating properties by comparing the kinetics (activation, inactivation, and deactivation) of the currents recorded in control cells and BMP-2-treated cells. As shown in Figure 2 , BMP-2 decelerated current activation (P<0.001) but accelerated current inactivation.
The time constant for current activation (τ act ) in BMP-2-treated PASMC was 5.25±1.96 fold higher (P<0.001) than τ act in control cells, while the time constant for current inactivation (τ inact )
in BMP-2-treated cells was 40% less (P<0.05) than τ inact in control cells ( Fig. 2A-C) . However, BMP-2 had negligible effect on current deactivation; the time constant for current deactivation (τ deact ) was comparable (P=0.14) in control and BMP-2-treated PASMC (Fig. 2D ). These results indicate that chronic treatment of human PASMC with BMP-2 has different effects on amplitude, current density, and kinetics of I K(V) . The BMP-2-mediated significant increase in current amplitude and density of I K(V) might be due to its upregulating effect on the channel expression (see below), whereas the BMP-2-mediated significant inhibition on current activation and slight (but statistically significant) acceleration of current inactivation might result from its potential effect on Kv channel gating and/or indirect effect on the channel gating via modulating intracellular signal transduction proteins and Kv channel regulatory subunits (e.g., β subunits). leaking currents, were all subtracted using the P/4 protocol. Therefore, the contribution of K T channels to the currents shown in Figure 1 is negligible.
BMP-2-enhanced
In PASMC, ATP-sensitive K + channels are completely inhibited by ~3 mM ATP in the pipette solution (16) . The currents in BMP-2-treated PASMC were recorded using the pipette solution containing 5 mM ATP, which would completely block ATP-sensitive K + channels and significantly limit the contribution of ATP-sensitive K + channels to the whole-cell currents shown in Figure 1 . Furthermore, the Ca 2+ -free pipette (intracellular) solution used in our study contained 10 mM EGTA, which would considerably reduce free [Ca 2+ ] in the cytosol when whole-cell recording configuration was formed. The Ca
2+
-free bath solution contained 1 mM EGTA, which would completely chelate all residual free Ca 2+ in the extracellular solution.
Accordingly, the currents recorded in cells superfused and dialyzed with these extracellular (bath) and intracellular (pipette) solutions should be mainly due to K + currents through Kv channels.
To verify that the BMP-2-sensitive outward K + currents was indeed carried mainly by K + efflux through Kv channels, we examined the acute effects of 4-aminopyridine (4-AP), a relatively selective blocker of Kv channels (57) , and charybdotoxin (ChTX), a specific Ca 2+ -activated K + channel blocker (57), on the currents recorded in BMP-2-treated PASMC. As shown in Figure 3 , extracellular application of 5 mM 4-AP significantly reduced the whole-cell K + currents elicited by depolarizing the cells to a series of test potentials ranging from -60 mV to +80 mV from a holding potential of -70 mV (Fig. 3A) . However, extracellular application of 50 nM ChTX had negligible effect on the currents (Fig. 3B) in human PASMC; the potential effect of BMP-2 on these channels might be masked by the special experimental conditions and protocols we used in this study. (Kv1.4, NS), and KCNC1 (Kv3.1, NS) by 1-2 fold; but the effect was not statistically significant.
BMP-2 differentially alters
The most dramatic changes observed were the downregulation of KCNG2 (Kv6.2) ( In addition to the quantitative real time RT-PCR experiments using cDNA isolated from proliferating PASMC (cultured in SMGM), we also determined the effects of BMP-2 on Kv channel α, β, and γ subunit expression in growth-arrested PASMC (cultured in SMBM) using regular RT-PCR and primers listed in Table 2 . Our results showed that BMP-2 (100 nM for 24 hrs) slightly downregulated KCNAB1 (Kvβ1) and KCNAB3 (Kvβ3), significantly upregulated ] (data not shown). Previously, we had shown that BMP-2-induced human PASMC apoptosis may be due to downregulation of Bcl-2, a membrane-bound antiapoptotic protein (106) , whose heightened expression we have also linked to the downregulation of Kv channel function and α subunit expression (12). Therefore, these results suggest that BMP-2-mediated enhancement of I K(V) and potential transcriptional regulation on Kv channel α/β/γ subunits may result, at least in part, from its downregulating effect on c-Myc (Fig. 6 ).
( In this study, we observed significant downregulation of the electrically silent KCNG2 (Fig. 7) . In prior studies, we showed that a) BMP-2 treatment caused marked downregulation of Bcl-2, an antiapoptotic protein (106), b) Bcl-2 decreased Kv subunit expression and channel activity and promoted PASMC survival (25) , and c) decreased
inhibits apoptosis or promotes survival of rat and human PASMC (13, (42) (43) (44) . By inference, this would suggest that BMP-2, by decreasing Bcl-2 expression, could enhance Kv expression and function to promote apoptosis. Our current findings suggest a link between BMP-2 function and Bcl-2 (25), an antiapoptotic protein that inhibits apoptosis and downregulates Kv channels, and c-Myc, a transcription factor that is upregulated during cell proliferation. In PASMC, activity of Kv channels is involved in regulating the resting membrane potential (100-102) and plays an important role in mediating apoptotic volume decrease and apoptosis (10) (11) (12) (13) (42) (43) (44) 
